Milestone Pharmaceuticals, Inc. (MIST)
0.52
-0.14
(-20.63%)
USD |
NASDAQ |
Nov 13, 16:00
0.505
-0.02
(-2.88%)
After-Hours: 19:59
Milestone Pharmaceuticals Total Liabilities (Quarterly) : 168.91M for Sept. 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 168.91M |
| June 30, 2026 | 163.41M |
| March 31, 2026 | 157.68M |
| December 31, 2025 | 71.79M |
| September 30, 2025 | 67.25M |
| June 30, 2025 | 65.16M |
| March 31, 2025 | 68.01M |
| December 31, 2024 | 62.35M |
| September 30, 2024 | 58.69M |
| June 30, 2024 | 57.25M |
| March 31, 2024 | 56.08M |
| December 31, 2023 | 58.46M |
| September 30, 2023 | 58.61M |
| June 30, 2023 | 56.61M |
| March 31, 2023 | 57.14M |
| December 31, 2022 | 8.135M |
| Date | Value |
|---|---|
| September 30, 2022 | 8.614M |
| June 30, 2022 | 4.64M |
| March 31, 2022 | 5.043M |
| December 31, 2021 | 7.249M |
| September 30, 2021 | 6.359M |
| June 30, 2021 | 5.901M |
| March 31, 2021 | 6.451M |
| December 31, 2020 | 6.855M |
| September 30, 2020 | 6.599M |
| June 30, 2020 | 5.123M |
| March 31, 2020 | 5.524M |
| December 31, 2019 | 8.511M |
| September 30, 2019 | 9.06M |
| June 30, 2019 | 6.524M |
| March 31, 2019 | 4.256M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| NervGen Pharma Corp. | 30.56M |
| Appili Therapeutics, Inc. | 15.82M |
| Clearmind Medicine, Inc. | 3.961M |
| Lexaria Bioscience Corp. | 0.4371M |
| Target Group, Inc. (Canada) | 14.33M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 162.70M |
| Shareholders Equity (Quarterly) | -6.217M |
| Debt to Equity Ratio | -23.12 |
| Current Ratio | 6.268 |
| Net Debt Paydown Yield | -16.21% |